A novel SOS1 mutation in Costello/CFC syndrome affects signaling in both RAS and PI3K pathways.
about
One-way membrane trafficking of SOS in receptor-triggered Ras activation.New innovations: therapeutic opportunities for intellectual disabilities.Monitoring the Waiting Time Sequence of Single Ras GTPase Activation Events Using Liposome Functionalized Zero-Mode Waveguides.A Thr72Ala polymorphism in the NKG2D gene is associated with early symptomatic congenital cytomegalovirus disease.
P2860
A novel SOS1 mutation in Costello/CFC syndrome affects signaling in both RAS and PI3K pathways.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A novel SOS1 mutation in Coste ...... in both RAS and PI3K pathways.
@en
A novel SOS1 mutation in Coste ...... in both RAS and PI3K pathways.
@nl
type
label
A novel SOS1 mutation in Coste ...... in both RAS and PI3K pathways.
@en
A novel SOS1 mutation in Coste ...... in both RAS and PI3K pathways.
@nl
prefLabel
A novel SOS1 mutation in Coste ...... in both RAS and PI3K pathways.
@en
A novel SOS1 mutation in Coste ...... in both RAS and PI3K pathways.
@nl
P2093
P2860
P1476
A novel SOS1 mutation in Coste ...... in both RAS and PI3K pathways.
@en
P2093
Junko Takita
Makiko Saitoh
Munkhtuya Tumurkhuu
Yoko Mizuno
P2860
P304
P356
10.3109/10799893.2013.779279
P577
2013-04-01T00:00:00Z